New drug offers hope for lupus patients
New drug offers hope for lupus patients
July 28th, 2009 by Valerie ChavezHuman Genome Sciences and GlaxoSmithKline announced positive results
July 21 from a yearlong clinical trial of Benlysta for treating lupus.
Lupus patients treated with Benlysta had improvement in overall disease
activity without clinically significant flare-ups in one or more
isolated organs when compared with patients who received the placebo.
Patients receiving the drug also were able to reduce their intake
of steroid medications. The study is the largest ever to be completed
for lupus and the first successful Phase III (late stage) trial of a
new biologic immune therapy.
No new drugs to treat lupus have been developed
and approved in more than 50 years, said Sandra Raymond, president and
CEO of the Lupus Foundation of America.
"These results provide hope that this complex chronic autoimmune
disease can be brought under control and that, eventually, a cure can
be found for the estimated 1.5 million Americans and more than 5
million people worldwide living with lupus," Raymond said last week in
a statement. If the FDA approves Benlysta, it will be the first drug
successfully developed to specifically treat lupus since the disease
was discovered more than a century ago.
LINK: http://www.cleveland.com/healthfit/index.ssf/2009/07/new_drug_offers_hope_for_lupus.html
Sign In to leave a comment.
Mike
Jayne
Pamela
Barb
wrightrs
Sarah